Figures & data
Figure 1. Level of vitamin E in urogenital tuberculosis patients and on treatment with anti Tb drugs.
![Figure 1. Level of vitamin E in urogenital tuberculosis patients and on treatment with anti Tb drugs.](/cms/asset/ac3186e7-1851-4063-9238-55cbc642ff2d/irnf_a_11379233_uf0001_b.gif)
Figure 2. A. Histology section of kidney normal architecture. B. Kidney section showing granulomatous inflammation, giant cells and caseation in GuTb patients. C. Presence of Mycobacterium tuberculosis (PAS staining). D. Histological section showing tubular impairment and abnormal granuloma in GuTb patients treated with antituberculosis drugs. E. Kidney section of GuTb patients treated along with vitamin E.
![Figure 2. A. Histology section of kidney normal architecture. B. Kidney section showing granulomatous inflammation, giant cells and caseation in GuTb patients. C. Presence of Mycobacterium tuberculosis (PAS staining). D. Histological section showing tubular impairment and abnormal granuloma in GuTb patients treated with antituberculosis drugs. E. Kidney section of GuTb patients treated along with vitamin E.](/cms/asset/16698d51-fd61-41b1-bb0c-fc9cb1371c28/irnf_a_11379233_uf0002_b.gif)
Table 1. Urinary Excretion of Renal Marker Enzymes
Table 2. Stone Risk Profile Determined in Urine of Urogenital Tuberculosis Patients Before and After Treatment of Regular Anti Tb Drugs Along with Vitamin E